Legal & General Group PLC Atreca, Inc. Transaction History

Legal & General Group PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$1.56 - $3.25 $3,263 - $6,799	-2,092 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.87 - $6.29 $18,537 - $40,627	-6,459 Reduced 75.54%	2,092 $6,000
Q3 2021 Nov 15, 2021	BUY	$4.91 - $9.07 $23,425 - $43,272	4,771 Added 126.22%	8,551 $54,000
Q2 2021 Aug 12, 2021	SELL	$7.82 - $13.8 $8,406 - $14,835	-1,075 Reduced 22.14%	3,780 $32,000
Q1 2021 May 17, 2021	SELL	$13.0 - $19.34 $1,573 - $2,340	-121 Reduced 2.43%	4,855 $74,000
Q3 2020 Nov 13, 2020	BUY	$12.67 - $23.19 $19,309 - $35,341	1,524 Added 44.15%	4,976 $70,000
Q2 2020 Aug 14, 2020	BUY	$12.52 - $23.45 $9,940 - $18,619	794 Added 29.87%	3,452 $73,000
Q1 2020 May 14, 2020	BUY	$11.4 - $27.28 $15,572 - $37,264	1,366 Added 105.73%	2,658 $43,000
Q4 2019 Feb 13, 2020	BUY	$9.68 - $18.67 $2,216 - $4,275	229 Added 21.54%	1,292 $20,000
Q3 2019 Nov 13, 2019	BUY	$10.42 - $22.04 $11,076 - $23,428	1,063 New	1,063 $13,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.